“Global Launch Strategies in the Current Political Climate”: Virax CEO, James Foster, discusses how global launches are being impacted by changing geopolitical conditions

Article by Mike Hollan

“Lyme Disease: Are we Close to an Effective Diagnostic Test?”: Dr. Nigel McCracken speaks to Clinical Lab Products Magazine

Article by Chris Wolski

“Combating chronic inflammation through immune diagnostics”: Dr. Nigel McCracken speaks to Longevity.Technology

Article by Eleanor Garth

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs: Interview With COO Nigel McCracken About The Diagnostics And Detection Company

by Amit Chowdhry of Pulse 2.0

A Diagnosis in Demand – The Urgent Need for Post-Acute Infection Syndrome (PAIS) Testing by Dr. Elihu Aranday-Cortes

Discovering Solutions for Long COVID: A T Cell Immunology Breakthrough (feat. Dr. Nigel McCracken)

by Tori Whitacre Martonicz of Infection Control Today

Detecting T Cell Dysfunction in Post-Acute Infection Syndromes (feat. Dr. Nigel McCracken)

by Sophia Abene of Contagion Live

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland